- Mass General study suggests specific populations of tumor cells have different roles
A study from Massachusetts General Hospital (MGH) researchers suggests that specific populations of tumor cells have differen Read More... - Fox Chase analysis finds more cutting-edge cancer research supported by industry
Nearly half of the research presented at ASCO’s annual meeting last year came from researchers with ties to companies, and Read More... - Multi-center team develops a new technique that reveals unseen information in DNA code
Imagine reading an entire book, but then realizing that your glasses did not allow you to distinguish “g” from “q.” W Read More... - University of Colorado study associates protein RAL with aggressive characteristics in prostate, bladder and skin cancers
We have known for years that when the proteins RalA and RalB are present, cells in dishes copy toward aggressive forms of can Read More... - In Georgetown University phase I study, combination of temsirolimus, temsirolimus proves safe; positive survival trend seen
A phase I clinical trial examining the safety of combining temsirolimus and capecitabine in advanced malignancies suggests th Read More...
- New Way to Target B-Cell Lymphomas
Researchers at the University of Pennsylvania have identified a protein that could be targeted to turn off B-cell lymphomas. Read More... - How I Survived Chemotherapy
I confess that I have never taken chemotherapy. Strictly speaking this disqualifies me from commenting any further, so I sho Read More... - Lenalidomide Maintenance for Multiple Myeloma Improves Survival
Three studies published this week show that lenalidomide improves progression-free and overall survival as a maintenance ther Read More... - Diffuse Large B-Cell Lymphoma: Current Treatment Approaches
This article examines clinical and biological features of DLBCL patients with poor outcomes, and reviews recent studies addre Read More... - Improving the Therapeutic Ratio in Hodgkin Lymphoma Through the Use of Proton Therapy
This review addresses the rationale and evidence for—and the challenges, cost implications, and future development of—pro Read More...
Male breast cancer is often overlooked. In this interview with CBS news, Patrick Cobb, MD, F.A.C.P., a practicing medical oncologist at Frontier Cancer Center in Billings, Montana, provides important educational information on the subject. In addition to daily patient clinical support, Dr. Cobb is a dedicated patient advocate. He is the immediate past president of the Community Oncology Alliance (COA) and currently serves as the Chairman of COA’s Policy Committee.